Author

Takahiro Tanaka

Tokushima UniversityORCID 0000-0002-4862-5259Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Akihiro HiraoiD· 1 shared Harumi KagiwadaiD· 1 shared Hironori TanakaiD· 1 shared Hiroshi MiyamotoiD· 1 shared Katsuhisa HorimotoiD· 1 shared Kazuhiko FukuiiD· 1 shared Koichi OkamotoiD· 1 shared Masahiro SogabeiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Akihiro HiraoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Therapeutic Efficacy and Safety of Lenvatinib for Unresectable Hepatocellular Carcinoma Beyond Progression with Sorafenib

Tetsu Tomonari, Yasushi Sato, Hironori Tanaka, Takahiro Tanaka, Yasuteru Fujino, Yasuhiro Mitsui, Akihiro Hirao, Tatsuya Taniguchi, Masahiro Sogabe, Koichi Okamoto, Hiroshi Miyamoto, Naoki Muguruma, Harumi Kagiwada, Masashi Kitazawa, Kazuhiko Fukui, , Tetsuji Takayama

This study evaluates lenvatinib's efficacy and safety as second/third-line treatment for unresectable HCC after sorafenib, showing higher response rates and survival in earlier lines and better liver function.

bioRxiv · Jan 3, 2020 · PreprintMolecular Biology